Geode Capital Management
KURA icon

Geode Capital Management’s Kura Oncology KURA Stock Holding History

Geode Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.5M Buy
2,229,958
+195,682
+10% +$1.85M ﹤0.01% 2032
2026
Q1 		$16.5M Buy
2,034,276
+5,658
+0.3% +$48.6K ﹤0.01% 2097
2025
Q4 		$21.1M Sell
2,028,618
-19,308
-0.9% -$203K ﹤0.01% 1976
2025
Q3 		$18.1M Buy
2,047,926
+33,897
+2% +$242K ﹤0.01% 2045
2025
Q2 		$11.6M Buy
2,014,029
+211,470
+12% +$1.3M ﹤0.01% 2262
2025
Q1 		$11.9M Buy
1,802,559
+20,515
+1% +$160K ﹤0.01% 2180
2024
Q4 		$15.5M Buy
1,782,044
+1,535
+0.1% +$22.1K ﹤0.01% 2096
2024
Q3 		$34.8M Buy
1,780,509
+41,535
+2% +$842K ﹤0.01% 1660
2024
Q2 		$35.8M Buy
1,738,974
+31,700
+2% +$652K ﹤0.01% 1585
2024
Q1 		$36.4M Buy
1,707,274
+51,265
+3% +$997K ﹤0.01% 1567
2023
Q4 		$23.8M Buy
1,656,009
+78,053
+5% +$768K ﹤0.01% 1807
2023
Q3 		$14.4M Buy
1,577,956
+249,840
+19% +$2.54M ﹤0.01% 2032
2023
Q2 		$14.1M Buy
1,328,116
+41,576
+3% +$492K ﹤0.01% 2090
2023
Q1 		$15.7M Buy
1,286,540
+57,110
+5% +$713K ﹤0.01% 1959
2022
Q4 		$15.3M Buy
1,229,430
+39,675
+3% +$577K ﹤0.01% 1955
2022
Q3 		$16.3M Sell
1,189,755
-14,555
-1% -$225K ﹤0.01% 1890
2022
Q2 		$22.1M Buy
1,204,310
+96,533
+9% +$1.39M ﹤0.01% 1696
2022
Q1 		$17.8M Sell
1,107,777
-96,049
-8% -$1.39M ﹤0.01% 1973
2021
Q4 		$16.9M Buy
1,203,826
+100,066
+9% +$1.62M ﹤0.01% 2075
2021
Q3 		$20.7M Sell
1,103,760
-46,397
-4% -$874K ﹤0.01% 1939
2021
Q2 		$24M Buy
1,150,157
+62,700
+6% +$1.56M ﹤0.01% 1845
2021
Q1 		$30.7M Buy
1,087,457
+91,966
+9% +$2.91M ﹤0.01% 1587
2020
Q4 		$32.5M Buy
995,491
+160,911
+19% +$5.65M 0.01% 1404
2020
Q3 		$25.6M Buy
834,580
+93,712
+13% +$2.07M 0.01% 1342
2020
Q2 		$12.1M Buy
740,868
+159,884
+28% +$2.31M ﹤0.01% 1816
2020
Q1 		$5.78M Buy
580,984
+60,842
+12% +$696K ﹤0.01% 2058
2019
Q4 		$7.15M Buy
520,142
+21,110
+4% +$313K ﹤0.01% 2237
2019
Q3 		$7.57M Buy
499,032
+57,702
+13% +$1.03M ﹤0.01% 2112
2019
Q2 		$8.69M Buy
441,330
+67,546
+18% +$1.12M ﹤0.01% 2051
2019
Q1 		$6.2M Buy
373,784
+19,774
+6% +$305K ﹤0.01% 2209
2018
Q4 		$4.97M Buy
354,010
+43,205
+14% +$572K ﹤0.01% 2231
2018
Q3 		$5.44M Buy
310,805
+35,794
+13% +$686K ﹤0.01% 2304
2018
Q2 		$5M Buy
275,011
+41,680
+18% +$706K ﹤0.01% 2325
2018
Q1 		$4.37M Buy
233,331
+66,417
+40% +$1.29M ﹤0.01% 2314
2017
Q4 		$2.55M Buy
166,914
+3,255
+2% +$48K ﹤0.01% 2616
2017
Q3 		$2.45M Buy
163,659
+90,740
+124% +$852K ﹤0.01% 2638
2017
Q2 		$678K Buy
72,919
+23,237
+47% +$212K ﹤0.01% 3253
2017
Q1 		$437K Buy
49,682
+426
+0.9% +$3.12K ﹤0.01% 3356
2016
Q4 		$290K Buy
49,256
+284
+0.6% +$1.52K ﹤0.01% 3465
2016
Q3 		$306K Buy
+48,972
New +$248K ﹤0.01% 3453

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management's KURA Position: Q2 2026 in Review

Geode Capital Management increased its Kura Oncology (KURA) stake by 9.6% in Q2 2026, buying an estimated $1.85M and bringing the position to 2,229,958 shares worth $24.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2032.

Geode Capital Management first reported a position in KURA in Q3 2016 and has held it in 40 quarters since. The position peaked at $36.4M in Q1 2024. 205 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Geode Capital Management held 2,229,958 shares of Kura Oncology worth $24.5M as of Q2 2026.
  • Geode Capital Management bought 195,682 Kura Oncology shares in Q2 2026, an estimated $1.85M.
  • Kura Oncology made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2032 holding.
  • Geode Capital Management first reported a position in Kura Oncology in Q3 2016 and has held it in 40 quarters since.
  • Geode Capital Management's Kura Oncology position peaked at $36.4M in Q1 2024.
  • 205 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.